Keratoconus patients more likely to develop sleep apnoea

Article

Keratoconus patients are more likely to develop sleep apnoea

Keratoconus patients are more likely to develop sleep apnoea, states a paper in the Journal of Cornea and External Disease.

Dr Michael Saidel, Section of Ophthalmology, University of Chicago, Illinois, USA, led a team that evaluated 92 keratoconus patients and 92 control patients. Each patient was classified as being high or low risk for sleep apnoea after answering the Berlin Questionnaire (BQ). The risk factors linked to high risk sleep apnoea was identified using logistic regression.

Out of the keratoconus patients questioned, 18 had a positive known sleep apnoea history and 49 were identified as high risk by the results of the BQ. Six of the 92 control patients had a positive known sleep apnoea history and 25 were identified as high risk.

In the control patients' age, body mass index and family history of sleep apnoea were the major risk factors for sleep apnoea. However, in keratoconus patients body mass index was the only risk factor for sleep apnoea.

The study results suggest that ophthalmologists should consider screening keratoconus patients for sleep apnoea.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.